Brought to you by 
LabCorp buys Monogram Biosciences for $107mm plus debt
16 Jul 2009
Executive Summary
Laboratory Corp. of America Holdings has initiated a tender offer to buy public personalized medicine firm Monogram Biosciences, paying $4.55 per share (a 146% premium) for a total of $106.9mm, plus debt. The buyout should cost LabCorp about $155mm.
Deal Industry
- In Vitro Diagnostics
- Pharmaceuticals
-
In Vitro Diagnostics
- Chemistry, Immunoassay
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Pharmacogenetics-Pharmacogenomics
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
LabCorp buys Monogram Biosciences for $107mm plus debt
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice